| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▲ | 1.50▲ | 1.50▲ | 1.55▼ | 1.26▲ |
| MA10 | 1.50▲ | 1.51▲ | 1.53▼ | 1.54▼ | 0.97▲ |
| MA20 | 1.51▲ | 1.54▼ | 1.56▼ | 1.33▲ | 1.37▲ |
| MA50 | 1.52▼ | 1.55▼ | 1.59▼ | 0.94▲ | 2.32▼ |
| MA100 | 1.55▼ | 1.57▼ | 1.40▲ | 1.45▲ | N/A |
| MA200 | 1.59▼ | 1.38▲ | 1.07▲ | 2.05▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.002▼ | -0.009▼ | 0.014▲ | 0.122▲ |
| RSI | 52.080▲ | 45.075▼ | 44.927▼ | 60.828▲ | 48.037▼ |
| STOCH | 36.111 | 39.082 | 18.391▼ | 64.396 | 54.221 |
| WILL %R | -25.000 | -69.565 | -78.788▼ | -40.979 | -33.129 |
| CCI | 59.916 | -50.304 | -76.049 | 37.078 | 89.689 |
|
Friday, February 27, 2026 07:38 AM
Investing.com -- TuHURA Biosciences Inc (NASDAQ:HURA) shares rose 7.4% Friday after the company announced it regained compliance with Nasdaq’s minimum bid price requirement.
|
|
Friday, February 27, 2026 05:39 AM
TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics ...
|
|
Friday, February 27, 2026 05:01 AM
TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/03/26 | 1.55 | 1.56 | 1.475 | 1.50 | 459,985 |
| 05/03/26 | 1.595 | 1.65 | 1.49 | 1.56 | 369,904 |
| 04/03/26 | 1.55 | 1.65 | 1.55 | 1.64 | 488,692 |
| 03/03/26 | 1.44 | 1.59 | 1.37 | 1.55 | 755,937 |
| 02/03/26 | 1.63 | 1.655 | 1.4827 | 1.52 | 618,305 |
| 27/02/26 | 1.55 | 1.8298 | 1.54 | 1.67 | 1,388,208 |
| 26/02/26 | 1.77 | 1.79 | 1.301 | 1.62 | 1,636,742 |
| 25/02/26 | 1.44 | 1.70 | 1.33 | 1.68 | 1,642,502 |
| 24/02/26 | 1.27 | 1.48 | 1.27 | 1.40 | 1,269,534 |
| 23/02/26 | 1.13 | 1.27 | 1.12 | 1.24 | 736,600 |
|
|
||||
|
|
||||
|
|